Target validation of G-protein coupled receptors

Drug Discovery Today

Volumn 7, Issue 4, 2002, Pages 235-246

  Wise, Alan ^a   Gearing, Katy ^a   Rees, Stephen ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; BUSPIRONE; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CALCIUM SENSING RECEPTOR; CATECHOLAMINE RECEPTOR; CETIRIZINE; CHEMOKINE RECEPTOR; FAMOTIDINE; G PROTEIN COUPLED RECEPTOR; GLYCOPROTEIN; LORATADINE; LOSARTAN POTASSIUM; MESSENGER RNA; METABOTROPIC RECEPTOR; MONTELUKAST; NEUROMEDIN U; NEUROPEPTIDE RECEPTOR; NOCICEPTIN; OLANZAPINE; OREXIN; PROLACTIN RELEASING FACTOR; PURINE P2Y RECEPTOR; RANITIDINE; RISPERIDONE; SALMETEROL XINAFOATE; SEROTONIN 5B RECEPTOR; SUMATRIPTAN SUCCINATE; TAGARNET; UNINDEXED DRUG; UROTENSIN II; DRUG RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN;

ASTHMA; BINDING SITE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLARA CELL; DNA SEQUENCE; DRUG ACTIVITY; DRUG IDENTIFICATION; DRUG INDUSTRY; DRUG MARKETING; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; VALIDATION PROCESS; ANIMAL; BIOLOGICAL MODEL; COMPUTER SIMULATION; DRUG EFFECT; DRUG MANUFACTURE; GENE EXPRESSION; PHARMACOLOGY; PHYSIOLOGY;

ANIMAL; COMPUTER SIMULATION; GENE EXPRESSION; GTP-BINDING PROTEINS; HUMAN; MODELS, BIOLOGICAL; ORPHAN DRUG PRODUCTION; PHARMACOLOGY; RECEPTORS, DRUG; ANIMALS; HUMANS;

EID: 0037082324     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(01)02131-6     Document Type: Review

References (84)

1. Drug discovery: A historical perspective
2. Initial sequencing and analysis of the human genome
3. The sequence of the human genome
4. A G-protein coupled receptor for leukotriene B4 that mediates chemotaxis
5. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein coupled receptor 1
6. Identification of a molecular target of psychosine and its role in globoid cell formation
7. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A
8. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G-protein coupled receptor GPR4
9. Receptor for the pain modulatory peptides NPFF and NPAF is an orphan G-protein coupled receptor
10. P2Y receptor distribution in human and mouse tissue
11. Current developments in G-protein coupled receptors
12. Tools for investigating functional interactions between ligands and G-protein coupled receptors
13. High-throughput screening for drug discovery
14. Functional coupling of mammalian receptors to the yeast mating pathway using novel yeast/mammalian G protein alpha-subunit chimeras
15. 16 couple a wide variety of receptors to phospholipase C
16. sα that alter the fidelity of receptor activation
17. Pigment dispersion in frog melanophores can be induced by a phorbol ester or stimulation of a recombinant receptor that activates phospholipase C
18. A method for evaluating the effects of ligands upon Gs protein-coupled receptors using a recombinant melanophore-based bio-assay
19. Use of constitutive G-protein coupled receptor activity for drug discovery
20. Receptor for motilin identified in the human gastrointestinal system
21. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein coupled receptor SLC-1
22. Molecular cloning and functional characterization of MCH2, a novel human MCH receptor
23. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
24. Identification of receptors for neuromedin U and its role in feeding
25. Neuromedin U is a potent agonist at the orphan G-protein coupled receptor FM3
26. Identification of the natural ligand of an orphan G-protein coupled receptor involved in the regulation of vasoconstriction
27. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66
28. Sphingosine-1-phosphate as a ligand for the G-protein coupled receptor EDG-1
29. Edg-2/Vzg-1 couples to the yeast pheromone response pathway selectively in response to lysophosphatidic acid
30. Characterization of a novel subtype of human G-protein coupled receptor for lysophosphatidic acid
31. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G-protein coupled receptor H218
32. Edg-6 as a putative sphingosine 1-phosphate receptor coupling to Ca(2+) signaling pathway
33. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
34. Identification of a novel sphingosine 1-phosphate receptor, Edg-8
35. Characterization of the human leukotriene 2 (CysLT2) receptor
36. Molecular cloning and characterization of a second cysteinyl leukotriene receptor: Discovery of a subtype selective agonist
37. Molecular cloning and characterization of another leukotriene B4 receptor
38. Molecular characterization of a novel type of histamine receptor preferentially expressed in leukocytes
39. Trace amines: Identification of a family of mammalian G-protein coupled receptors
40. A G-protein coupled receptor for UDP-glucose
41. Molecular characterization of the melanin-concentrating hormone receptor
42. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
43. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behaviour
44. The hypocretins: Hypothalamic-specific peptides with neuroexcitatory activity
45. A prolactin-releasing peptide in the brain
46. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor
47. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
48. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein coupled receptor
49. AXOR12, a novel human G-protein coupled receptor, activated by the peptide KiSS-1
50. Molecular cloning of a novel G-protein coupled receptor that may belong to the neuropeptide receptor family
51. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type
52. Independent feeding and metabolic actions of orexins in mice
53. The effect of the orexins on food intake: Comparison with neuropeptide Y, melanin-concentrating hormone and galanin
54. Orexin A activates locus coeruleus cell firing and increases arousal in the rat
55. Down regulation of the prepro-orexin gene expression in genetically obese mice
56. SB-334867-A: The first selective orexin-1 receptor antagonist
57. Characterisation of the CCR2 chemokine receptor: Functional CCR2 receptor expression in B cells
58. CCR3 blockade as a new therapy for asthma
59. Human G-protein coupled receptor GPR-9-6/cc chemokine receptor 9 is selectively expressed on intestinal homing T lymphocytes, mucosal lymphocytes, and thymocytes and is required for thymus-expressed chemokine-mediated chemotaxis
60. Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion
61. CXCR4 mediates entry and productive infection of syncytia-inducing (X4) HIV-1 strains in primary macrophages
62. The experimental use of antisense oligonucleotides: A guide for the perplexed
63. G-protein coupled receptors: Functional and mechanistic insights through altered gene expression
64. Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes
65. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats
66. Decreased insulin content and secretion in RIN 1046-38 cells overexpressing alpha 2-adrenergic receptors
67. Rewarding effects of opiates are absent in mice lacking the receptor for substance P
68. Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean
69. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors
70. Altered emotional behaviour in PACAP-type-I-receptor-deficient mice
71. B1-deficient mice
72. Engineering receptors activated solely by synthetic ligands (RASSLs)
73. Novel neurotransmitters as natural ligands of orphan G-protein coupled receptors
74. alpha-latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein coupled receptor
75. BRS-3: A novel bombesin receptor subtype selectively expressed in testis and lung carcinoma cells
76. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
77. Molecular cloning and characterization of the human anaphylatoxin C3a receptor
78. Characterization of the human cysteinyl leukotriene CysLT1 receptor
79. Identification and characterisation of two G-protein coupled receptors for neuropeptide FF
80. ADP is the cognate ligand for the orphan G-protein coupled receptor SP1999
81. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seven-transmembrane receptor CRTH2
82. Expression of P2Y receptor subtypes in human tissues and cell lines determined by quantitative RT-PCR analysis
83. Orphan G-protein coupled receptors: The next generation of drug targets?